Milford Funds Ltd. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 112,646 shares of the company’s stock, valued at approximately $52,590,000. Milford Funds Ltd. owned 0.05% of HCA Healthcare as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the business. Korea Investment CORP grew its holdings in HCA Healthcare by 10.1% during the 4th quarter. Korea Investment CORP now owns 156,185 shares of the company’s stock worth $72,917,000 after acquiring an additional 14,322 shares during the period. Y Intercept Hong Kong Ltd grew its holdings in shares of HCA Healthcare by 403.1% in the 4th quarter. Y Intercept Hong Kong Ltd now owns 8,190 shares of the company’s stock valued at $3,824,000 after buying an additional 6,562 shares during the period. L1 Capital International Pty Ltd grew its holdings in shares of HCA Healthcare by 180.5% in the 4th quarter. L1 Capital International Pty Ltd now owns 91,987 shares of the company’s stock valued at $42,945,000 after buying an additional 59,188 shares during the period. Sumitomo Life Insurance Co. grew its holdings in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the period. Finally, Kane Investment Management Inc. acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $469,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
Analysts Set New Price Targets
HCA has been the subject of several research analyst reports. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Wells Fargo & Company cut their price objective on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research report on Monday, April 27th. Leerink Partners cut their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Finally, Robert W. Baird cut their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $506.14.
HCA Healthcare Price Performance
HCA Healthcare stock opened at $387.25 on Friday. The firm has a market capitalization of $85.91 billion, a PE ratio of 13.32, a P/E/G ratio of 1.20 and a beta of 1.12. The company’s 50-day moving average is $429.60 and its 200-day moving average is $473.48. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
